0001654954-24-007461.txt : 20240606 0001654954-24-007461.hdr.sgml : 20240606 20240606182645 ACCESSION NUMBER: 0001654954-24-007461 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240606 DATE AS OF CHANGE: 20240606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marchiando Keith CENTRAL INDEX KEY: 0001291432 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40449 FILM NUMBER: 241026699 MAIL ADDRESS: STREET 1: C/O ZIVO BIOSCIENCE, INC. STREET 2: 21 E. LONG LAKE ROAD, SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zivo Bioscience, Inc. CENTRAL INDEX KEY: 0001101026 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870699977 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 BUSINESS PHONE: (248) 452 9866 MAIL ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH ENHANCEMENT PRODUCTS INC DATE OF NAME CHANGE: 20040202 FORMER COMPANY: FORMER CONFORMED NAME: WESTERN GLORY HOLE INC DATE OF NAME CHANGE: 19991215 4 1 section16.xml FORM 4 X0508 4 2024-06-05 0001101026 Zivo Bioscience, Inc. ZIVO 0001291432 Marchiando Keith C/O ZIVO BIOSCIENCE, INC. 21 EAST LONG LAKE ROAD, SUITE 100 BLOOMFIELD HILLS MI 48304 false true false false Chief Financial Officer false Nonstatutory Stock Option to Purchase Common Stock 67.20 2024-06-05 4 D false 27083 D 2030-12-31 Common Stock 27083 0 D Nonstatutory Stock Option to Purchase Common Stock 33.00 2024-06-05 4 D false 48000 D 2031-10-20 Common Stock 48000 0 D Nonstatutory Stock Option to Purchase Common Stock 23.64 2024-06-05 4 D false 10333 D 2032-08-28 Common Stock 10333 0 D Nonstatutory Stock Option to Purchase Common Stock 7.96 2024-06-05 4 A false 444498 A 2034-06-04 Common Stock 444498 444498 D The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 80 reverse stock split of the Issuer's stock in May 2021 and a 1 for 6 reverse stock split of the Issuer's stock in October 2023, as applicable. The canceled option was fully vested. The Issuer canceled options for an aggregate 85,416 shares of the Issuer's common stock granted to the Reporting Person on 1/1/2021, 10/21/2021, and 8/29/2022. In exchange for the canceled options, the Reporting Person received a replacement option, for 444,498 shares, having an exercise price of $7.96. The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 10/21/2021 and vested as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant. The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 8/29/2022 and vested as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant. The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 328,065 immediately upon grant acceptance, 13,551 on July 1, 2024, 13,442 on August 28, 2024, 62,447 on October 21, 2024, 13,551 on January 1, 2025, and 13,442 on August 28, 2025. /s/ Keith Marchiando 2024-06-06